These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6874726)

  • 1. Estrogen receptor-mediated cytotoxicity using iodine-125.
    Bloomer WD; McLaughlin WH; Milius RA; Weichselbaum RR; Adelstein SJ
    J Cell Biochem; 1983; 21(1):39-45. PubMed ID: 6874726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of 125I-oestrogen decay in non-oestrogen receptor-expressing human breast cancer cells, MDA-231 and oestrogen receptor-expressing MCF-7 cells.
    Yasui LS; Hughes A; Desombre ER
    Int J Radiat Biol; 2001 Sep; 77(9):955-62. PubMed ID: 11576455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes.
    Kassis AI; Sastry KS; Adelstein SJ
    Radiat Res; 1987 Jan; 109(1):78-89. PubMed ID: 3809393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotoxicity of 125I in mammalian cells.
    Kassis AI; Fayad F; Kinsey BM; Sastry KS; Taube RA; Adelstein SJ
    Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
    Schomäcker K; Fischer T; Böttcher B; Mraheel SA; Scharl A; Gabruk-Szostak B; Scheidhauer K; Göhring UJ; Meller-Rehbein B; Shukla SK; Schicha H
    Nuklearmedizin; 1998 Jun; 37(4):134-40. PubMed ID: 9650213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhomogeneity of the nucleus to 125IUdR cytotoxicity.
    Yasui LS; Hofer KG; Warters RL
    Radiat Res; 1985 Apr; 102(1):106-18. PubMed ID: 3920724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
    Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ
    Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative biological effectiveness of accumulated 125IdU and 125I-estrogen decays in estrogen receptor-expressing MCF-7 human breast cancer cells.
    Yasui L; Hughes A; DeSombre E
    Radiat Res; 2001 Feb; 155(2):328-34. PubMed ID: 11175668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [125I]iodotamoxifen cytotoxicity in cultured human (MCF-7) breast cancer cells.
    McLaughlin WH; Pillai KM; Edasery JP; Blumenthal RD; Bloomer WD
    J Steroid Biochem; 1989 Oct; 33(4A):515-9. PubMed ID: 2811361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotoxicity of Auger electron-emitting estrogens in MCF-7 spheroids: a potential treatment for estrogen receptor-positive tumors.
    Kearney T; Hughes A; Hanson RN; DeSombre ER
    Radiat Res; 1999 May; 151(5):570-9. PubMed ID: 10319730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethylstilbestrol (DES) labeled with Auger emitters: potential radiopharmaceutical for therapy of estrogen receptor-positive tumors and their metastases?
    Fischer T; Schomacker K; Schicha H
    Int J Radiat Biol; 2008 Dec; 84(12):1112-22. PubMed ID: 19061136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell killing induced by decay of 125I during the cell cycle: comparison of 125I-antipyrine with 125I-bovine serum albumin.
    Miyazaki N; Shinohara K
    Radiat Res; 1993 Feb; 133(2):182-6. PubMed ID: 8438059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E; Borgna JL; Rochefort H
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.